Home Weight loss (GLP-1) By state Illinois
Illinois State Workers' GLP-1 Law: 8 programs ship to IL
Illinois is one of the few states that wrote GLP-1 coverage into law, but only for its own employees. Since July 1, 2024, the state employee plan must cover injectable weight-loss drugs. Illinois Medicaid does not. The lowest price we found from a program that ships to Illinois: compounded semaglutide at $89 a month on a 12-month plan ($99 month to month) at Lttl.
Illinois at a glance
- Illinois Medicaid
- Does not cover for weight loss
- State employee plan
- Covers GLP-1s for weight loss
- Adults with obesity
- 33.7% (2025)
- Programs we compare that ship to IL
- 8 of 22
Online GLP-1 programs for Illinois, cheapest first
Programs that ship to Illinois. Prescribed online by a licensed clinician; medication and delivery included.
How we pick and check programs
Our pick for November 2026

A daily oral GLP-1 plan. No needles, no injections
Compounded semaglutide in Illinois: lowest monthly price
| # | Program | Lowest price | Month to month | Link |
|---|---|---|---|---|
| 1 | LttlCheapest | $89/mo 12-month plan | $99 / 4 wks | VisitLttl |
| 2 | BetterMe Rx | $99/mo 12-month plan | $199/mo | VisitBetterMe Rx |
| 3 | Refills | $99/mo | $99 / 4 wks | VisitRefills |
| 4 | Direct Meds | $297/mo | $297/mo | VisitDirect Meds |
| 5 | Gala | From $69/mo starting price, plan length not stated | Not stated | VisitGala |
| 6 | TrimRx | From $349/mo starting price, plan length not stated | Not stated | VisitTrimRx |
Compounded tirzepatide in Illinois: lowest monthly price
| # | Program | Lowest price | Month to month | Link |
|---|---|---|---|---|
| 1 | MaximusCheapest | $99.99/mo 12-month plan | Not offered | VisitMaximus |
| 2 | Lttl | $139/mo 12-month plan | $149 / 4 wks | VisitLttl |
| 3 | BetterMe Rx | $159/mo 12-month plan | $249/mo | VisitBetterMe Rx |
| 4 | Refills | $159/mo | $159 / 4 wks | VisitRefills |
| 5 | Direct Meds | $399/mo | $399/mo | VisitDirect Meds |
| 6 | Gala | From $99/mo starting price, plan length not stated | Not stated | VisitGala |
| 7 | TrimRx | From $279/mo starting price, plan length not stated | Not stated | VisitTrimRx |
- Low month-to-month#1
Up to $140 off your first monthCompounded semaglutide for $99, month to month
Semaglutide$99/momonth to month (4-week supply); $89 on a 12-month planVisit Lttl Read our Lttl review - Pills or shots#2
Semaglutide from $99/moChoose weekly shots or daily tablets; shots from $99/mo on the 12-month plan
Semaglutide shots from$99/moon the 12-month plan; $199 month to monthVisit BetterMe Rx Read our BetterMe Rx review - No contract#3
Fall sale: 40% offCompounded semaglutide as low as $99 a month
Semaglutide as low as$99/moper 4-week supply, month to month; shown during a 40% fall sale4.2 on Trustpilot1,779 reviews ·Visit Refills Read our Refills review - Low-cost tirzepatide#4
Same price at every doseCompounded tirzepatide from $99.99 a month
Tirzepatide from$99.99/moon the 12-month plan, paid up front; $199.99 on 2 months4.4 on Trustpilot1,106 reviews ·Visit Maximus Read our Maximus review - Delivery in 1-2 days#5
Fall sale: $150 offSame price at every dose, at your door in 1-2 days
Semaglutide$297/momonth to month: medication, doctor visits and shipping included; tirzepatide $399; fall sale: "starting at $147", "$150 off"4.5 on Trustpilot17,724 reviews ·Visit Direct Meds Read our Direct Meds review
3 more programs are in the price tables above.
Illinois wrote GLP-1 coverage into law, for some
Section 6.11C of the State Employees Group Insurance Act requires coverage of medically necessary injectable drugs prescribed to help with weight loss or blood sugar for adults with obesity, prediabetes or past gestational diabetes. It applies to every health plan in the state employee program and took effect July 1, 2024. Governor Pritzker told CBS Mornings in September 2026 that the state plan covers GLP-1s for 55,000 state employees.
There is a condition. After the first prescription, members must enroll in their health plan's lifestyle management program. If you do not enroll or stop taking part, later fills can be denied. The program is run by your health plan, not by the state, so the steps differ between plans. Ask your plan how to sign up right after your first fill, and keep proof that you enrolled.
None of this reaches Illinois Medicaid, which still does not cover GLP-1s for obesity, or most private employer plans in Chicago and downstate. If your plan is one of those, online programs that ship to Illinois are the quickest way to compare real monthly prices. Check whether each program includes follow-up care and dose changes in the monthly price it quotes.
- 5 ILCS 375/6.11C requires the State Employees Group Insurance Program to cover medically necessary injectable drugs for weight loss or glucose control for adults with obesity, prediabetes or past gestational diabetes. (ilga.gov)
- Illinois state employees must enroll in a lifestyle management program after the first GLP-1 prescription to keep coverage. (cms.illinois.gov)
- Governor Pritzker told CBS Mornings on September 21, 2026 that Illinois covers GLP-1s on the state insurance plan for 55,000 state employees. (cbsnews.com)
- KFF's January 2026 review lists Illinois Medicaid as not covering GLP-1s for obesity. (kff.org)
- Illinois's adult obesity rate was 33.7% in 2025. (cdc.gov)
- Illinois Medicaid's Preferred Drug List effective October 20, 2026 lists Wegovy (pen and tablet) and Zepbound (single-dose pen and KwikPen) as non-preferred anti-obesity agents and states they will not be covered for weight loss alone. (hfs.illinois.gov)
- The same list covers Wegovy for MACE and MASH only, and Zepbound for obstructive sleep apnea only. (hfs.illinois.gov)
- In the October 20, 2026 list's diabetes class, Trulicity and Victoza are preferred, the Ozempic tablet and Rybelsus are preferred with prior authorization, and the Ozempic pen and Mounjaro are non-preferred. (hfs.illinois.gov)
What the October 2026 Illinois Medicaid drug list says
Illinois Medicaid publishes one Preferred Drug List, and the version that took effect October 20, 2026 has a class called anti-obesity GIP and GLP-1 receptor agonists. Four products sit in it: the Wegovy pen, the Wegovy tablet and two Zepbound pens (the single-dose pen and the multi-dose KwikPen). All four are marked non-preferred, which means a prescriber has to ask for approval first.
The notes under the class are short and specific. Wegovy is covered for MACE and MASH only. MACE means lowering the risk of a heart attack, stroke or heart-related death in someone who already has heart disease. MASH is a fatty liver disease with scarring. Zepbound is covered for obstructive sleep apnea only. The last note settles the question most people are asking: Wegovy and Zepbound will not be covered for weight loss alone.
These carve-outs are new. Earlier 2026 versions of the list had no anti-obesity class at all, so a doctor who checked in the spring may have told you nothing was covered. If you had a heart attack or stroke, have peripheral artery disease, or were diagnosed with sleep apnea on a sleep study, it is worth asking your prescriber to look again. The approval still depends on records, so bring the dates of past events and any sleep test results to the visit.
So an Illinois Medicaid member with a past heart attack, diagnosed sleep apnea or MASH has a real path to one of these drugs, and their doctor should know about it. A member whose only diagnosis is obesity does not. For that group, the cash programs below are the practical route, and several post one price at every dose.
Diabetes GLP-1s on Illinois Medicaid: the tablets come first
Type 2 diabetes is handled in a separate class of the same list, and the ranking there surprises people. Trulicity, Victoza and generic liraglutide pens are preferred. The Ozempic tablet and Rybelsus are preferred with prior authorization. The Ozempic pen and Mounjaro are both non-preferred, so a request for either one needs prior approval.
Diabetes coverage does not stretch to weight loss. The diabetes class is for blood sugar control, and the anti-obesity class rules out weight loss alone. If you have type 2 diabetes and your doctor wants Mounjaro, expect paperwork. If you do not have diabetes, a diabetes drug will not be approved for you through Medicaid.
Illinois sits below every neighbor on obesity, and still pays a price
CDC's 2025 numbers put Illinois at 33.7% of adults with obesity. That is lower than every bordering state: Kentucky at 38.8%, Indiana at 37.5%, Iowa at 36.9%, and Missouri and Wisconsin at 36.6% each. It is still one adult in three.
A lower rate has not meant wider coverage. The 2024 law covers state workers, Medicaid covers only the heart, liver and sleep apnea uses, and private employer plans in Chicago and downstate decide one by one. If you are in the gap, compare cash programs on what they include: the clinician visit, follow-up messages and whether the price moves when the dose rises.
Distance also shapes the choice. In Chicago and the collar counties, in-person weight clinics and med spas are easy to find, but their prices are often posted only after a consultation. Downstate, from the Quad Cities to Carbondale, the nearest specialist can be an hour or more away. Online programs quote their monthly prices up front and ship to any Illinois address, which makes a side-by-side comparison possible before you book anything.
GLP-1 in Illinois: questions
Does Illinois law require insurers to cover GLP-1s?
Only for the state employee plan. Since July 1, 2024, the State Employees Group Insurance Program must cover medically necessary injectable weight-loss drugs for qualifying adults. Private insurers and Medicaid are not covered by that rule. If your plan says no, compare the self-pay programs on this page.
What is the lifestyle management program for Illinois state workers?
After your first GLP-1 prescription, you must contact your health plan and enroll in its lifestyle management program. If you fail to enroll or stop participating, future coverage will be denied. If that does not fit your schedule, self-pay online programs have no such requirement. See options above.
Does Illinois Medicaid cover Wegovy for weight loss?
No. Illinois Medicaid covers GLP-1s for type 2 diabetes (some need prior authorization), but not for obesity, based on KFF's January 2026 review. Wegovy can be covered only to lower heart risk or for the liver disease MASH. Members who want treatment for weight alone can use a low-cost online program. The table lists programs that ship to Illinois.
Can I get semaglutide online in Chicago?
Yes. Online programs serve Chicago, the suburbs and downstate Illinois. A clinician licensed in Illinois reviews your health form, and medication ships to your door. Compare monthly prices, what is included and how prices change as your dose goes up in our table.
Does Blue Cross Blue Shield of Illinois cover Zepbound?
It depends on your employer's plan. BCBSIL administers many plans with different drug lists, and weight-loss coverage often needs prior authorization or is excluded. Check your member portal for Zepbound and Wegovy. If neither is covered, the self-pay options on this page are a direct way to start.
Does Illinois Medicaid cover Zepbound for sleep apnea?
Yes, that is the one use the October 2026 drug list allows for Zepbound. It is listed as non-preferred, so your prescriber needs prior approval and will usually send sleep study results. Zepbound is not covered for weight loss alone on Illinois Medicaid.
Why is Mounjaro harder to get than Trulicity on Illinois Medicaid?
Because of where each one sits on the state's drug list. Trulicity and Victoza are preferred for type 2 diabetes, while Mounjaro and the Ozempic pen are non-preferred. Non-preferred drugs need prior authorization, often after preferred options. Your doctor can explain which route fits your case.
Where can I find tirzepatide in Chicago without insurance?
Online programs that ship to Chicago and the rest of Illinois sell compounded tirzepatide at a monthly cash price, with the clinician review included. Compare the month-to-month price with longer plans, since the gap can be large, and check whether the price stays the same as your dose goes up.
Can Illinois Medicaid cover Wegovy after a heart attack?
Yes, that is one of the two uses the October 2026 drug list allows. Wegovy is covered for lowering heart risk (MACE) and for the liver disease MASH, both with prior approval because it is non-preferred. Ask your prescriber to send your heart history with the request.
See programs for Illinois All states
Sources: kff.org · cdc.gov · cms.illinois.gov